796 related articles for article (PubMed ID: 2881552)
1. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
[TBL] [Abstract][Full Text] [Related]
2. Squamous-cell carcinoma, Kaposi's sarcoma and Burkitt's lymphoma are consequences of impaired immune surveillance of ubiquitous viruses in acquired immune deficiency syndrome, allograft recipients and tropical African patients.
Purtilo DT; Manolov G; Manolova Y; Harada S; Lipscomb H
IARC Sci Publ; 1984; (63):749-70. PubMed ID: 6100288
[TBL] [Abstract][Full Text] [Related]
3. Human lymphotropic viruses associated with lymphoid malignancy: Epstein-Barr and HTLV-1.
Ambinder RF
Hematol Oncol Clin North Am; 1990 Aug; 4(4):821-33. PubMed ID: 2172203
[TBL] [Abstract][Full Text] [Related]
4. Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells.
Katsuki T; Katsuki K; Imai J; Hinuma Y
Jpn J Cancer Res; 1987 Jul; 78(7):639-42. PubMed ID: 3040648
[TBL] [Abstract][Full Text] [Related]
5. The roles of human viruses in the pathogenesis of lymphoma.
Lyons SF; Liebowitz DN
Semin Oncol; 1998 Aug; 25(4):461-75. PubMed ID: 9728596
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
7. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.
Birx DL; Redfield RR; Tosato G
N Engl J Med; 1986 Apr; 314(14):874-9. PubMed ID: 3005862
[TBL] [Abstract][Full Text] [Related]
8. Human T lymphotropic virus-type I Tax induction of CD21/Epstein-Barr virus receptor expression on T cells and its significance in leukemogenesis of adult T cell leukemia.
Ohtsubo H; Arima N; Matsushita K; Hidaka S; Fujiwara H; Arimura K; Kukita T; Fukumori J; Matsumoto T; Eizuru Y; Tanaka H
Exp Hematol; 1997 Nov; 25(12):1246-52. PubMed ID: 9357968
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus permissively infects human syncytiotrophoblasts in vitro and induces replication of human T cell leukemia-lymphoma virus type I in dually infected cells.
Tóth FD; Aboagye-Mathiesen G; Nemes J; Liu X; Andirkó I; Hager H; Zdravkovic M; Szabó J; Kiss J; Aranyosi J; Ebbesen P
Virology; 1997 Mar; 229(2):400-14. PubMed ID: 9126252
[TBL] [Abstract][Full Text] [Related]
10. Immunodeficiency as a factor in lymphomagenesis.
Purtilo DT; Sakamoto K
Perspect Pediatr Pathol; 1984; 8(2):181-91. PubMed ID: 6330665
[TBL] [Abstract][Full Text] [Related]
11. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1].
Kwon KW
Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883
[TBL] [Abstract][Full Text] [Related]
12. [Biology of the Epstein-Barr virus].
Morand P; Seigneurin JM
Ann Biol Clin (Paris); 1989; 47(7):421-7. PubMed ID: 2554764
[TBL] [Abstract][Full Text] [Related]
13. Role of Epstein-Barr virus in the etiology of Burkitt's lymphoma.
Purtilo DT; Manolov G; Manolova Y; Harada S; Lipscomb H; Tatsumi E
IARC Sci Publ; 1985; (60):231-47. PubMed ID: 2998991
[TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
[TBL] [Abstract][Full Text] [Related]
15. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.
Cohen JI
Semin Hematol; 2003 Apr; 40(2):116-23. PubMed ID: 12704588
[TBL] [Abstract][Full Text] [Related]
16. Human retroviruses in health and disease.
Weiss RA
Princess Takamatsu Symp; 1984; 15():3-12. PubMed ID: 6100647
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
18. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.
Katsuki T; Yamaguchi K; Matsuoka Y; Hinuma Y
AIDS Res; 1986 Dec; 2 Suppl 1():S125-30. PubMed ID: 3030343
[TBL] [Abstract][Full Text] [Related]
19. A pathogenic retrovirus (HTLV-III) linked to AIDS.
Broder S; Gallo RC
N Engl J Med; 1984 Nov; 311(20):1292-7. PubMed ID: 6208484
[TBL] [Abstract][Full Text] [Related]
20. Human T-cell lymphotropic virus type-I infection in the severe combined immunodeficiency mouse.
Furlan R; Salazar-Grueso EF; Martino G; Roos RP; Brambilla E; Castellano M; Cao J; Lillo F; Terreni MR; Bacellar H; Dorigatti F; Grimaldi LM
J Med Virol; 1996 Jun; 49(2):77-82. PubMed ID: 8991939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
